Etentamig

(Synonyms: ABBV-383; TNB 383B)
Customer Review

Based on 1 Customer Validation

Etentamig is a T cell engager targeting BCMA and CD3. Etentamig redirects T cell-mediated cytotoxicity by binding BCMA (Kd = 0.7 nM) and activating the T cell co-receptor CD3 (Kd = 1.3 mM), mediates BCMA-specific plasma cell killing and target cell lysis, and has low-activation properties that decouple T cell activation from cytokine release. Etentamig exhibits anti-myeloma efficacy and can be used in research on relapsed/refractory multiple myeloma.

For research use only. We do not sell to patients.

  • Purity : 99%
  • CAS No.: 2490552-52-6
  • Molecular Weight:123.8 kDa
  • Storage:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00